Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Available in both sterile and bacteriostatic formulations
How the oral quadruple agonist's results built across Phase 1 and Phase 2
pilot human infusions well tolerated Learn More TB-500 Overview TB-500 Overview Mechanisms: Binds actin to enhance cytoskeletal remodeling and cell migrationcritical for tissue repair Learn More Primary Uses: Muscle tears, tendon/ligament injuries, cardiac protection Learn More Administration: Subcutaneous or intramuscular injections (not orally bioavailable) Safety Highlights: Low acute toxicity in animal models
Individuals with Gastrointestinal Disorders Conditions like Crohns disease or celiac disease can impair B12 absorption
Studied for the complementary action of the two peptides
trials in healthy adults are small and limited in scope
US$ 21.32
US$ 23.89
US$ 21.28
US$ 25.06
US$ 20.27
US$ 29.15
